Massachusetts To Lead Digital Health Innovation


Massachusetts is recognized as the #1 hub for life sciences in the world. In fact, five of the top six NIH-funded independent hospitals are in Massachusetts and Mass. receives 57% of all NIH funding to independent hospitals: Mass. General, Brigham and Women's, Boston Children's, Dana-Farber, and Beth Israel Lahey Health. Combined with biopharma, all life sciences companies in Massachusetts raised $3.6 billion in venture capital investment in 2017 and US-based investors outside of Massachusetts led 60% of the investment into Massachusetts-based biopharma companies in 2017.

Building on Massachusetts' success as a biotech supercluster with an innovation economy second to none, the Commonwealth is now officially a big player in digital health.